| 000 | 01697 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513131445.0 | ||
| 264 | 0 | _c19971204 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a0002-9343 | ||
| 024 | 7 |
_a10.1016/s0002-9343(97)00164-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZorich, N L | |
| 245 | 0 | 0 |
_aA randomized, double-blind study of the effect of olestra on disease activity in patients with quiescent inflammatory bowel disease. Olestra in IBD Study Group. _h[electronic resource] |
| 260 |
_bThe American journal of medicine _cNov 1997 |
||
| 300 |
_a389-99 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAbdominal Pain _xetiology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdiet therapy |
| 650 | 0 | 4 |
_aCrohn Disease _xdiet therapy |
| 650 | 0 | 4 |
_aDiarrhea _xetiology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aFat Substitutes _xpharmacology |
| 650 | 0 | 4 |
_aFatty Acids _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSucrose _xanalogs & derivatives |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aJones, M B | |
| 700 | 1 | _aKesler, J M | |
| 700 | 1 | _aCarter, S B | |
| 700 | 1 | _aSutton, M A | |
| 700 | 1 | _aBayless, T | |
| 773 | 0 |
_tThe American journal of medicine _gvol. 103 _gno. 5 _gp. 389-99 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9343(97)00164-2 _zAvailable from publisher's website |
| 999 |
_c9345573 _d9345573 |
||